Nitta J, Sunami A, Furukawa T, Marumo F, Sawanobori T, Hiraoka M
Tokyo Medical and Dental University, Japan.
Cardiovasc Res. 1992 May;26(5):462-9. doi: 10.1093/cvr/26.5.462.
The aim was to study the difference between tonic and use dependent block of the cardiac sodium channel produced by the combined application of the same subclass of antiarrhythmic agents (class Ia or Ib).
Conventional glass microelectrode technique was used to record the maximum rate of depolarisation (dV/dtmax) of action potentials reflecting sodium channel availability, before and after the combined application of quinidine plus disopyramide, aprindine plus lignocaine, aprindine plus mexiletine, and lignocaine plus mexiletine. Guinea pig papillary muscles (n = 4-8 per experiment) were used for the study.
All combinations increased tonic block additively compared to use of a single drug. On the other hand, use dependent block was increased by the combination of quinidine 10 microM plus disopyramide 30 microM compared to a single drug, and was not changed by lignocaine 50 microM plus mexiletine 20 microM, whereas it was decreased by aprindine 3 microM plus lignocaine 50 microM or mexiletine 20 microM. When concentrations of mexiletine and lignocaine were increased, both tonic and use dependent block in a single drug were increased dose dependently, whereas the combination produced an additive increase in tonic block but no change in use dependent block compared to a single drug.
The results suggested that the binding and unbinding process of the drug to produce tonic block was different from that to produce use dependent block, and that combination of different drugs produced diverse effects on use dependent block even though state dependent affinity of individual drugs seemed similar. These two factors must be born in mind in evaluating the combination therapy.
研究联合应用同一亚类抗心律失常药物(Ia类或Ib类)所产生的心脏钠通道的强直阻滞和使用依赖性阻滞之间的差异。
采用传统玻璃微电极技术记录在联合应用奎尼丁加双异丙吡胺、阿普林定加利多卡因、阿普林定加美西律以及利多卡因加美西律前后反映钠通道可用性的动作电位最大去极化速率(dV/dtmax)。实验使用豚鼠乳头肌(每个实验n = 4 - 8)。
与单一药物使用相比,所有联合用药均能增强强直阻滞作用。另一方面,与单一药物相比,10微摩尔/升奎尼丁加30微摩尔/升双异丙吡胺的联合用药增加了使用依赖性阻滞,而50微摩尔/升利多卡因加20微摩尔/升美西律的联合用药对其无影响,3微摩尔/升阿普林定加50微摩尔/升利多卡因或20微摩尔/升美西律的联合用药则使其降低。当美西律和利多卡因浓度增加时,单一药物的强直阻滞和使用依赖性阻滞均呈剂量依赖性增加,而联合用药与单一药物相比,强直阻滞呈相加性增加,使用依赖性阻滞无变化。
结果表明,药物产生强直阻滞的结合和解离过程与产生使用依赖性阻滞的过程不同,并且不同药物的联合应用对使用依赖性阻滞产生不同影响,尽管各药物的状态依赖性亲和力似乎相似。在评估联合治疗时必须牢记这两个因素。